Group 1 - The Supervisory Board of Jinan Hengyu Environmental Technology Co., Ltd. held its third meeting of the fourth session on August 26, 2025, to review and approve various proposals [1][2] - The Supervisory Board approved the company's 2025 semi-annual report and its summary, confirming that the report reflects the company's actual situation accurately and completely [2][3] - The Supervisory Board also approved a special report on the storage and actual use of raised funds for the first half of 2025, ensuring compliance with relevant regulations [2][3] Group 2 - The company plans to use up to RMB 350 million of idle self-owned funds for cash management to enhance efficiency and returns while ensuring safety and normal operations [3][4] - The cash management products will include safe and liquid investments, such as structured deposits and time deposits, with a maximum investment period of one year [4][5] - The Supervisory Board confirmed that the cash management plan aligns with the interests of the company and its shareholders, posing no risk to the company's operations [5][6] Group 3 - The Supervisory Board approved the cancellation of 644,464 shares of unvested restricted stock due to certain incentive targets not being met and the departure of three incentive recipients [6]

Core Points - The company raised a total of RMB 300 million through the issuance of convertible bonds, with a net amount of RMB 294.73 million after deducting issuance costs [1][2] - As of June 30, 2025, the company has not utilized any of the raised funds for investment projects, and the remaining balance in the special account is RMB 3.13 million [1][2] - The company has implemented a management system for the raised funds to ensure compliance with regulations and protect investor interests [1][2] Fundraising Overview - The company issued 3 million convertible bonds at a face value of RMB 100 each, resulting in total fundraising of RMB 300 million [1] - After deducting issuance costs of RMB 5.27 million, the actual net amount raised was RMB 294.73 million, which was fully received by September 18, 2023 [1][2] Fund Usage and Balance - No funds have been used for investment projects as of the reporting date, with a total of RMB 653,004.81 earned from bank interest and investment products [1][2] - The company has temporarily invested RMB 150 million of the raised funds in financial products, with a remaining balance of RMB 3.13 million in the special account [1][2] Fund Management - The company has established a dedicated management system for the raised funds, ensuring they are stored in special accounts and managed according to regulatory requirements [1][2] - The company has signed tripartite agreements with banks and sponsors to clarify the rights and obligations of all parties involved in fund management [1][2] Temporary Fund Supplementation - The company has temporarily used RMB 100 million of the raised funds to supplement working capital, with a commitment to return these funds to the special account within 12 months [2][3] - As of March 21, 2025, the company has fully returned the temporarily used funds to the special account [3] Cash Management - The company has approved the use of up to RMB 230 million of idle raised funds for cash management, focusing on safe and liquid investment products [4] - As of the reporting date, the company has earned RMB 653,004.81 from cash management activities, with a remaining balance of RMB 150 million in financial products [4]

Core Viewpoint - The document outlines the management measures for the use of raised funds by Shanghai RunDa Medical Technology Co., Ltd, emphasizing the need for compliance with legal regulations and the protection of investors' rights [1]. Group 1: General Principles - The purpose of the management measures is to standardize the use and management of raised funds, ensuring investor rights are protected [1]. - The term "raised funds" refers to funds obtained through stock issuance for specific purposes, excluding funds raised for equity incentive plans [1]. - The measures apply to the storage, use, change of purpose, supervision, and accountability of raised funds [1]. Group 2: Fund Storage - Raised funds must be stored in a special account approved by the board of directors, and cannot be used for non-raised fund purposes [2]. - A tripartite supervision agreement must be signed with the sponsor and the commercial bank within one month of the funds being received [2]. - The agreement includes provisions for monthly bank statements and conditions under which the sponsor can investigate the fund usage [2][3]. Group 3: Fund Usage - The company must follow strict procedures for fund usage, including approval from relevant departments based on project implementation progress [3]. - Any significant deviations from the planned use of funds must be reported to the Shanghai Stock Exchange [3]. - The company is prohibited from using raised funds for financial investments or providing funds to related parties for improper benefits [4][5]. Group 4: Changes in Fund Allocation - Changes in the use of raised funds must be approved by the board and the shareholders, with clear justifications provided [10]. - New investment projects must be analyzed for feasibility and profitability to mitigate investment risks [10][11]. Group 5: Management and Supervision - The company is required to disclose the actual use of raised funds accurately and completely [27]. - Independent directors must monitor the management of raised funds, and external auditors may be engaged for verification [27][28]. - The sponsor must conduct regular investigations into the fund management and usage, providing reports to the company and the stock exchange [29].

Meeting Overview - The 17th meeting of the fourth Supervisory Board of Zhejiang Yanpai Filter Technology Co., Ltd. was held on August 25, 2025, with all three supervisors present [1] - The meeting was chaired by Ms. Sun Xiaoyang and complied with relevant laws and regulations [1] Resolutions Passed - The Supervisory Board approved the company's 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's situation without any false statements or omissions [2] - The board also approved the special report on the use of raised funds for the first half of 2025, affirming compliance with regulations and no misuse of funds [2] - An adjustment to the grant price of the 2022 restricted stock incentive plan was approved, aligning with legal requirements and not harming minority shareholders' interests [3] - The board agreed to void 903,468 shares of restricted stock that had been granted but not vested, in accordance with relevant regulations [4]

新疆东方环宇燃气股份有限公司（股票代码：603706） 募集资金管理和使用办法 新疆东方环宇燃气股份有限公司 募集资金管理和使用办法 新疆东方环宇燃气股份有限公司（股票代码：603706） 募集资金管理和使用办法 新疆东方环宇燃气股份有限公司 募集资金管理和使用办法 第一章 总则 第一条 新疆东方环宇燃气股份有限公司（以下简称"公司"）为规范募集资金的 存放、使用和管理，保证募集资金的安全，保障投资者的合法权益，根据《中华人 民共和国公司法》 （以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称 "《证券法》"） 、《上海证券交易所股票上市规则》 （以下简称"《上市规则》"） 、《上市公司 募集资金监管规则》《上海证券交易所上市公司自律监管指引第1号—— 规范运作》 等法律、法规和规范性文件的规定并结合公司实际情况，特制定本办法。 第二条 本办法所称募集资金，是指公司通过发行股票或者其他具有股权性 质的证券，向投资者募集并用于特定用途的资金，但不包括公司为实施股权激励 计划募集的资金。 本办法所称超募资金是指实际募集资金净额超过计划募集资金金额的部分。 第三条 公司的董事和高级管理人员应当勤勉尽责， ...

公司为提高募集资金使用效益，将部分暂时闲置募集资金购买结构性存款、收 益凭证、通知存款。 证券代码：688230 证券简称：芯导科技 公告编号：2025-021 上海芯导电子科技股份有限公司 情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 按照中国证监会《上市公司募集资金监管规则》、上海证券交易所颁布的《上 海证券交易所科创板上市公司自律监管指引第1号——规范运作》及相关格式指引 的要求，现将上海芯导电子科技股份有限公司（以下简称"公司"、"本公司"） 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 经中国证券监督管理委员会《关于同意上海芯导电子科技股份有限公司首次公 开发行股票注册的批复》（证监许可[2021]3364号）的批准，公司2021年12月于上 海证券交易所向社会公众公开发行人民币普通股(A股)15,000,000.00股，发行价为 币175,256,603.78元，余额为人民币1,846,893,396.22元，另外扣除中介机构费和其 他发行费用人民币16,404,716.98元（ ...

Summary of Key Points Core Viewpoint The announcement provides a detailed account of Jiangsu Suli Fine Chemical Co., Ltd.'s fundraising activities, including the amount raised, its usage, and the management of the funds, ensuring compliance with regulatory requirements. Fundraising Overview - The company raised a total of RMB 957.21 million through the issuance of convertible bonds, with a net amount of RMB 943.62 million after deducting issuance costs [1]. - The funds were deposited into a dedicated account approved by the board of directors and have been verified by an accounting firm [1]. Previous Year Fund Usage - As of December 31, 2024, the cumulative investment from the raised funds amounted to RMB 671.38 million, with RMB 131.69 million initially invested from the company's own funds [2]. - By June 30, 2025, the total investment from the raised funds reached RMB 779.63 million, with RMB 108.25 million used in the current year [2]. Fund Management and Storage - The company has established a management system for the raised funds in accordance with relevant laws and regulations to protect investor interests [4]. - Multiple dedicated accounts have been opened at various banks for the management of the raised funds, ensuring that the funds are used strictly for their intended purposes [5]. Cash Management of Idle Funds - The company has approved the use of idle raised funds for cash management, allowing for investment in low-risk financial products to enhance returns while ensuring that the investment plans are not affected [8]. - The company has received returns from cash management activities, with specific amounts detailed for each fiscal year [8]. Changes in Fund Usage - The company has proposed changes to the investment projects funded by the raised capital, increasing the production capacity of certain chemical products [9]. - The total planned investment for the revised projects is RMB 148.33 million, with the amount from raised funds remaining at RMB 94.36 million [9]. Compliance and Reporting - The company has adhered to regulatory requirements for the management and usage of raised funds, with no violations reported [9]. - Detailed reports on the usage of funds have been disclosed, ensuring transparency and accountability [9].

Summary of Key Points Core Viewpoint The report provides an overview of the fundraising activities, management, and usage of funds by Guangzhou Shanshui Bide Design Co., Ltd. for the first half of 2025, highlighting compliance with regulatory requirements and the effective management of raised funds. Fundraising Overview - The company raised a total of RMB 81,032.30 million from the issuance of 10.1 million shares at RMB 80.23 per share, with a net amount of RMB 69,131.09 million after deducting issuance costs of RMB 11,901.21 million [1][2]. - As of June 30, 2025, the remaining balance of the raised funds was RMB 19,136.33 million after various expenditures [2][3]. Fund Usage and Management - The company directly invested RMB 14,451.64 million into committed projects and allocated RMB 17,000 million for financial products [2][3]. - The company established a special account for fundraising and signed a tripartite supervision agreement with several banks to ensure proper management and usage of the funds [3][4]. Fund Allocation and Returns - The company utilized RMB 3,368.60 million of the raised funds during the reporting period [5][6]. - The company has temporarily supplemented working capital with idle funds, with a total of RMB 5,000 million used for this purpose, all of which has been returned to the special account within the stipulated time [6][7][8]. Use of Excess Funds - The company has utilized a total of RMB 18,171.89 million of excess funds for permanent working capital supplementation, with approvals from independent directors and the underwriting institution [9][10][11]. Compliance and Reporting - The company has adhered to relevant regulations and guidelines in disclosing the management and usage of raised funds, with no violations reported [12][13][14].

Core Viewpoint - The company plans to temporarily use part of its idle raised funds, not exceeding RMB 650 million, to supplement working capital for a period of up to 12 months, ensuring that this does not affect the normal operation of its fundraising investment projects [5][6][7]. Fundraising Overview - The company raised a total of RMB 633.3122 million by issuing 189.975024 million shares at a price of RMB 11.88 per share, with the funds deposited in a designated account [1]. - As of June 30, 2025, the company has invested RMB 127.05519 million, or 84.70% of the planned investment, in its projects, including the repayment of bank loans [2]. Use of Idle Funds - The company has approved the use of RMB 154.3961 million of excess raised funds for new projects, specifically the Yi'an Warehouse Smart Supply Chain Project, with RMB 43.9055 million already utilized as of June 30, 2025 [3]. - The company has also approved the use of up to RMB 230 million of idle funds for cash management, with RMB 139 million already invested in structured deposits and time deposits [3]. Temporary Working Capital Supplement - The decision to use idle funds for working capital is based on maximizing shareholder interests while ensuring the ongoing funding needs of investment projects are met [5][6]. - The board and supervisory committee have unanimously agreed that this use of funds will not change the purpose of the raised funds or harm shareholder interests [6][7]. Regulatory Compliance - The proposal to use idle funds has been reviewed and approved by the board and supervisory committee, complying with relevant regulations and guidelines [7].

| 证券代码：605033 证券简称：美邦股份 公告编号：2025-045 | | | | | --- | --- | --- | --- | | 陕西美邦药业集团股份有限公司 | | | | | 2025 年半年度募集资金存放与实际使用情况的 | | | 关于 | | 专项报告的公告 | | | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 | | | | | 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 | | | | | 根据中国证券监督管理委员会《上市公司募集资金监管规则》以及《上海证 | | | | | 券交易所上市公司自律监管指引第1号——规范运作》《上海证券交易所股票上 | | | | | 市规则》等有关规定，将陕西美邦药业集团股份有限公司（以下简称本公司、公 | | | | | 司或美邦股份）2025年半年度募集资金存放与使用情况报告如下： | | | | | 一、募集资金基本情况 | | | | | （一）实际募集资金金额、资金到位情况 | | | | | 经中国证券监督管理委员会《关于核准陕西美邦药业集团股份有限公司首次 | | | | ...